Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial

por prodriguez | Ene 1, 2021 | Publicaciones - CIMO-02

Nishio, M; Barlesi, F; West, H; Ball, S; Bordoni, R; Cobo, M; Longeras, PD; Goldschmidt, J; Novello, S; Orlandi, F; Sanborn, RE; Szalai, Z; Ursol, G; Mendus, D; Wang, LJ; Wen, XH; McCleland, M; Hoang, T; Phan, S; Socinski, MA – 2021

Osimertinib Maintenance After Definitive Chemoradiation in Patients With Unresectable EGFR Mutation Positive Stage III Non-small-cell Lung Cancer: LAURA Trial in Progress

por prodriguez | Ene 1, 2021 | Publicaciones - CIMO-02

Lu, S; Casarini, I; Kato, T; Cobo, M; Ozguroglu, M; Hodge, R; van der Gronde, T; Saggese, M; Ramalingam, SS – 2021

Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

por prodriguez | Ene 1, 2021 | Publicaciones - CIMO-02

Lee, NY; Ferris, RL; Psyrri, A; Haddad, RI; Tahara, M; Bourhis, J; Harrington, K; Chang, PMH; Lin, JC; Razaq, MA; Teixeira, MM; Lovey, J; Chamois, J; Rueda, A; Hu, CS; Dunn, LA; Dvorkin, MV; De Beukelaer, S; Pavlov, D; Thurm, H; Cohen, E – 2021

PD-(L)1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer Patients with High PD-L1 Expression: A Network Meta-Analysis

por prodriguez | Ene 1, 2021 | Publicaciones - CIMO-02

Majem, M; Cobo, M; Isla, D; Marquez-Medina, D; Rodriguez-Abreu, D; Casal-Rubio, J; Moran-Bueno, T; Bernabe-Caro, R; Perez-Parente, D; Ruiz-Gracia, P; Arroyo, MM; Paz-Ares, L – 2021

Biomarkers Associated with Regorafenib First-Line Treatment Benefits in Metastatic Colorectal Cancer Patients: REFRAME Molecular Study

por prodriguez | Ene 1, 2021 | Publicaciones - CIMO-02

Conde, E; Earl, J; Crespo-Toro, L; Blanco-Agudo, C; Ramos-Munoz, E; Rodriguez-Serrano, EM; Avila, JCM; Salinas-Munoz, L; Serrano-Huertas, S; Ferreiro, R; Rodriguez-Garrote, M; Sainz, B; Massuti, B; Alfonso, PG; Benavides, M; Aranda, E; Garcia-Bermejo, ML; Carrato, A...

Pretreatment Tissue TCR Repertoire Evenness Is Associated with Complete Pathologic Response in Patients with NSCLC Receiving Neoadjuvant Chemoimmunotherapy

por prodriguez | Ene 1, 2021 | Publicaciones - CIMO-02

Casarrubios, M; Cruz-Bermudez, A; Nadal, E; Insa, A; Campelo, MDG; Lazaro, M; Domine, M; Majem, M; Rodriguez-Abreu, D; Martinez-Marti, A; de Castro-Carpeno, J; Cobo, M; Lopez-Vivanco, G; Del Barco, E; Caro, RB; Vinolas, N; Aranda, IB; Viteri, S; Massuti, B; Barquin,...